---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-029050"
form_type: "8-K"
ticker: "DMII"
cik: "0002040475"
company_name: "Drugs Made In America Acquisition II Corp."
filed_at: "2026-03-17T23:59:59+00:00"
generated_at: "2026-05-15T11:06:59.533266+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Drugs Made In America Acquisition II Corp. issues $150K convertible bridge note as part of $1.4M financing

## Summary
- On March 11, 2026, Company issued a $150,000 unsecured convertible bridge note to Alpha Multi Family Office (Investor).
- The bridge note is part of a larger $1,400,000 convertible notes financing under a Letter of Intent dated March 5, 2026 and an addendum dated March 9, 2026.
- The note matures nine months from issuance, bears no interest, and is convertible at a 35% discount to market price upon a business combination.
- The Company plans to use proceeds for accounting, audit, and other expenses related to the business combination.
- The LOI originally contemplated $1,500,000 but was reduced to $1,400,000 after $100,000 in advisor fees.

## SEC filing metadata
- accession: 0001213900-26-029050
- form_type: 8-K
- ticker: DMII
- cik: 0002040475
- company_name: Drugs Made In America Acquisition II Corp.
- filed_at: 2026-03-17T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2040475/000121390026029050/0001213900-26-029050-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2040475/000121390026029050/ea0281959-8k_drugs2.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-029050
- JSON: https://secwatch.observer/filing/0001213900-26-029050.json
- Plain text: https://secwatch.observer/filing/0001213900-26-029050.txt

## Source-grounded claims
- claim_id: 267b8676975fe9bb73cf18586014edcb01dafbde
  claim: Drugs Made In America Acquisition II Corp. incurred convertible notes of $150,000 with Alpha Multi Family Office at does not bear interest maturing nine months from the date of issuance.
  evidence_excerpt: On March 11, 2026, Drugs Made In America Acquisition II Corp. (the “ Company ”) issued an unsecured convertible note (the “ Bridge Note ”) to Alpha Multi Family Office (the “ Investor ”) in the principal amount of $150,000 (the “ Bridge Loan ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/2040475/000121390026029050/0001213900-26-029050-index.htm
- claim_id: c7df68800c0a7f4159d71d5728d9a63f8c1256bd
  claim: Drugs Made In America Acquisition II Corp. entered into Bridge Note with Alpha Multi Family Office valued at $150,000 (effective 2026-03-11).
  evidence_excerpt: On March 11, 2026, Drugs Made In America Acquisition II Corp. (the “ Company ”) issued an unsecured convertible note (the “ Bridge Note ”) to Alpha Multi Family Office (the “ Investor ”) in the principal amount of $150,000 (the “ Bridge Loan ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/2040475/000121390026029050/0001213900-26-029050-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.